Publisher Correction: Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: the BRAIN-AF randomized clinical trial

Q: What is the clinical evidence from this study?

Population: Atrial fibrillation. Intervention: Anticoagulation.

Léna Rivard; Paul Khairy; Mario Talajic; Jeffrey S. Healey; Sandra E. Black; Jason Andrade; Thalia S. Field; Isabelle Nault; L. Bherer; Fadi Massoud; Stanley Nattel; Sylvain Lanthier; Normand Racine; Jean-François Roux; Isabelle Greiss; Laurent Macle; P. G. Guerra; Rafik Tadros; Hélène Mayrand; Gilbert Gosselin; David Conen; Christian Bocti; Céline Chayer; Yan Deschaintre; Roopinder K. Sandhu; Jaimie Manlucu; Yaariv Khaykin; Atul Verma; Blandine Mondésert; Katia Dyrda; Julia Cadrin-Tourigny; B. Thibault; Alexandre Raymond-Paquin; Martín Aguilar; Judith Brouillette; André Roussin; Alain Robillard; Maxime Tremblay-Gravel; Louis‐Philippe David; Mariève Cossette; Marie-Claude Guertin; Denis Roy; on behalf of the BRAIN-AF investigators; A. Shekhar Pandey; FRANCIS PICHETTE; Miguel Barrero; Teresa Kuś; Ariane Lemieux; Valérie Gaudreault; Peiman Marzban; Jorge Wong; PETER LEONG SIT; David F Laflamme; Ronald A.F. Fowlis; Kenneth Quadros; Anmol Kapoor; Umjeet Jolly; Stephen Wilton; Fabian Alejandro Azzari; Paul Dorian; François Deslongchamps; Yves Pesant; Saul Vizel; TunZan Maung; Pablo B. Nery; Greg Curnew; Stéphanie Bourgeois; Vidal Essebag; Simon Kouz; Luc Cormier; John Vyselaar; R Chehayeb; Clarence Khoo; Anil Gupta; Ricardo Bessoudo; RAKESH BHARGAVA; F. Sandrin; Gernot Schram; François St-Maurice; Winston Tsui; William Liang

doi:10.1038/s41591-026-04245-5

February 1, 2026Nature MedicineOpen Access

Publisher Correction: Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: the BRAIN-AF randomized clinical trial

View Full Paper

Ask AI

Bookmark

Share

Key result

Publisher correction updates author list for BRAIN-AF trial with no new clinical data.

Key Points

To correct the author listing of the BRAIN-AF randomized clinical trial by removing duplicate investigator entries.
The HTML and PDF versions of the original publication were updated to modify the presentation of the author list.
Members of the BRAIN-AF investigators group now appear solely in the consortium author list rather than in both the main author and consortium lists.

PICO

P

Population

Atrial fibrillation

I

Intervention / Comparator

Anticoagulation

Implication

Author correction to BRAIN-AF adds no clinical data; leaves trial results and interpretations unchanged for clinicians and researchers.

Abstract

In the version of the article initially published, the members of the BRAIN-AF investigators group appeared in both the main author list and the consortium author list. This has now been corrected in the HTML and PDF versions of the article, so that they only appear in the consortium author list.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rivard et al. (2026) studied Atrial fibrillation. Anticoagulation was evaluated. This is a publisher correction regarding the author list for the BRAIN-AF randomized clinical trial and contains no clinical efficacy or safety data.

synapsesocial.com/papers/6a025a6d9cddff7633412c26 https://doi.org/10.1038/s41591-026-04245-5

View Full Paper

Ask AI

Bookmark

Share

Publisher Correction: Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: the BRAIN-AF randomized clinical trial

Key Points

PICO

Implication

Abstract

Discussion

Cite This Study

Publisher Correction: Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: the BRAIN-AF randomized clinical trial

Key Points

PICO

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading